Page last updated: 2024-09-03

2,5-bis(3,4,5-trimethoxyphenyl)tetrahydrofuran and Leukopenia

2,5-bis(3,4,5-trimethoxyphenyl)tetrahydrofuran has been researched along with Leukopenia in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Altavilla, D; Arena, A; Campo, GM; Caputi, AP; Santoro, G; Squadrito, F; Sturniolo, R1
Biftu, T; Doebber, TW; Wu, MS1

Other Studies

2 other study(ies) available for 2,5-bis(3,4,5-trimethoxyphenyl)tetrahydrofuran and Leukopenia

ArticleYear
Platelet activating factor involvement in splanchnic artery occlusion shock in rats.
    European journal of pharmacology, 1991, Jan-03, Volume: 192, Issue:1

    Topics: 6-Ketoprostaglandin F1 alpha; Animals; Arterial Occlusive Diseases; Blood Pressure; Furans; Leukocyte Count; Leukopenia; Macrophages; Male; Phagocytosis; Platelet Activating Factor; Radioimmunoassay; Rats; Rats, Inbred Strains; Shock; Splanchnic Circulation; Thromboxane B2; Tumor Necrosis Factor-alpha

1991
Inhibition of the platelet activating factor (PAF)-induced in vivo responses in rats by trans-2,5-(3,4,5-trimethoxyphenyl) tetrahydrofuran (L-652,731), a PAF receptor antagonist.
    The Journal of pharmacology and experimental therapeutics, 1986, Volume: 239, Issue:3

    Topics: Acetylglucosaminidase; Animals; Blood Pressure; Endotoxins; Female; Furans; Hydrolases; Leukopenia; Lysosomes; Neutropenia; Platelet Activating Factor; Rats; Rats, Inbred Strains

1986